Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STRATA sertraline for anxiety in autistic adults
ACTRN12621000801819Phase 4Active, not recruiting
- Sponsor
- The University of Western Australia
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in anxiety disorder comparing Sertraline with Placebo (2 arms). Primary endpoint: Change in anxiety severity at 16 weeks. Started Feb 2022; status: active, not recruiting.
02
Drugs
sertraline
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on ACTRN12621000801819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621000801819.